期刊文献+

筛选可注射型人工髓核材料的体外细胞毒性测试 被引量:1

Basic sieving of an injectable prosthetic nucleus pulposus by studying cytotoxicity in vitro
原文传递
导出
摘要 目的经体外细胞毒性测试初步筛选一类新型的聚醚型聚氨酯作为可注射型人工髓核材料。方法设置5个实验组:即样品1、2、3组为加入不同配比催化剂合成的软硬段配比不同的聚醚型聚氨酯;样品4组是不加催化剂,在37℃下经缓慢聚合而成的聚醚型聚氨酯;样品5组为单体有毒基团完全反应的聚醚型聚氨酯。另设1个对照组为不含材料浸提液的培养基。称取每组实验材料各0.6mg,经消毒后分别制成浸提液,经稀释50%后培养小鼠成纤维细胞(L929细胞),分别培养至第3天、4天、5天,使用3-(4,5-二甲基-2-噻唑)-2,5-二苯基溴化四唑(MTT)比色法比较材料组与对照组间酶联免疫分析法测得的490nnl处的0D值,计算细胞相对增殖率,来评价材料的细胞毒性。结果样品4组和样品5组与对照组相比,L929细胞相对增殖率没有显著性差异,细胞毒性分级属于o~1级;样品1-3组与对照组L929细胞相对增殖率比较,差异有统计学意义,细胞毒性1~2级,但细胞形态正常。结论未加催化剂的体内聚合聚氨酯材料没有细胞毒性,具有作为髓核替代材料的应用潜力。加入催化剂后快速聚合的材料毒性有待进一步测试。 To sieve a new type of polyether polyurethane as an injectable prosthetic nucleus pulpous through testing the cytotoxicity in vitro. Methods Five experimental groups were set as following: that sampies 1, 2, 3 groups were polyether-polyurethane polymerized of different ratio of soft and hard segment with different catalysts; group 4 was polyether polyurethane polymerized slowly at 37 cC without catalyst; group 5 was polyether polyurethane that toxic monomer responded completely. Additionally, a control group of culture medium was set without material extracts. Get 0.6 mg from each sample product and make into material extracts after disinfection, then dilution them by 50% and culture the mouse fibroblasts (cell L929) until 3 d, 4 d, 5 d, by Adopting 3-(4, 5-dimethyl-2-thiazolyl)-2, 5-diphenyl tetrazolium bromide (MTI') colorimetric method to compare the 490 nm OD between the materials and control groups obtained by enzyme linked immune analysis, calculate the RGR of cells, and then evaluating the cytotoxicity of the materials. Results The RGR of L929 cell in group 4 and group 5 have no significant difference compared to the control group. Cytotoxic levels were 0 to 1; difference of the RGR of L929 cell between group 1-3 and control group were statistically significant. Cytotoxic levels were 1 to 2, but the cell morphology was normal. Conclusion The material polymerized without catalyst does not show cytotoxicity, and has great potential to be used as a substitute for nucleus pulposus. The cytotoxicity of the materials polymerized with catalyst needs to be tested
出处 《中华骨科杂志》 CAS CSCD 北大核心 2011年第7期806-810,共5页 Chinese Journal of Orthopaedics
基金 国家高科技研究发展(863)计划(2006AA0224D4)
关键词 材料试验 细胞毒性试验 免疫 椎间盘 Materials testing Cytotoxicity tests immunologic Intervertebral disk
  • 相关文献

参考文献19

  • 1Klara PM, Ray CD. Artificial nucleus replacement: clinical expe- rience. Spine (Phila Pa 1976), 2002, 27(12):1374-1377.
  • 2Bao QB, Yuan HA. New technologies in spine: nucleus replace- ment. Spine (Phila Pa 1976), 2002, 27(11):1245-1247.
  • 3Di Martino A, Vaecaro AR, Lee JY, et al. Nucleus pulposus replacement: basic science and indications for clinical use. Spine (Phila Pa 1976), 2005, 30(16 Suppl):S16-22.
  • 4Boelen EJ, Koole LH, van Rhijn LW, et al. Towards a functional radiopaque hydrogel for nucleus pulposus replacement. J Biomed Mater Res B Appl Biomater, 2007, 83(2): 440-450.
  • 5Kaibara M, Kawamoto Y, Yanagida S, et al. In vitro evaluation ofantithrombogenicity of hybrid-type vascular vessel models based on analysis of the mechanism of blood coagulation. Biomaterials, 1995, 16(16):1229-1234.
  • 6程晓非,邹德威,吴继功,庹新林,王晓工,刘俊丽,马华松,张瑞娟,路浩军.新型可注射性人工髓核的体外细胞毒性测试[J].第三军医大学学报,2009,31(5):412-415. 被引量:6
  • 7白克文,邹德威,吴继功,程晓非,周雪峰,马华松.新型原位聚合注射性人工髓核假体的遗传毒性研究[J].解放军医学杂志,2009,34(10):1185-1187. 被引量:1
  • 8姬勇,邹德威,吴继功,庹新林,王晓工,王婧,周雪峰,马华松.新型可注射性人工髓核的生物力学测试[J].中国脊柱脊髓杂志,2009,19(5):376-380. 被引量:3
  • 9Fernstrom U. Arthroplasty with intercom)oral endoprothesis in herniated disc and in painful disc. Acta Chir Scand Suppl, 1966, 357:154-159.
  • 10Eyholzer C, Borges de Couracqa A, Duc F, et al. Biocomposite hydrogels with carboxymethylated, nanofibrillated cellulose pow- der for replacement of the nucleus pulposus. Biomacromolecules, 2011, 12(5):1419-1427.

二级参考文献73

共引文献21

同被引文献45

  • 1关海森,吕宏乐,刘全喜,王黎明,范波胜.Solis椎间融合器固定与钛板固定治疗颈椎病的对比研究[J].中国实用医刊,2010,37(3):93-94. 被引量:1
  • 2Itz CJ,Geurts JW,van Kleef M. Clinical course of non-specific low back pain:a systematic review of prospective cohort studies set in primary care[J].European Journal of Pain,2013,(01):5-15.
  • 3Chaichana KL,Mukherjee D,Adogwa O. Correlation of preoperative depression and somatic perception scales with postoperative disability and quality of life after lumbar discectomy[J].Journal of Neurosurgery-Spine,2011,(02):261-267.
  • 4Nel ensteijn J,Ostelo R,Bartels R. Transforaminal endoscopic surgery for symptomatic lumbar disc herniations:a systematic review of the literature[J].European Spine Journal,2010,(02):181-204.
  • 5Schoenfeld AJ. Adjacent segment degeneration after lumbar spinal fusion:risk factors and implications for clinical practice[J].Spine Journal,2011,(01):21-23.
  • 6Videbaek TS,Bünger CE,Henriksen M. Sagittal spinal balance after lumbar spinal fusion:the impact of anterior column support results from a randomized clinical trial with an eight-to thirteen-year radiographic fol ow-up[J].Spine,2011,(03):183-191.
  • 7Kim CH,Chung CK,Jahng TA. Comparisons of outcomes after single or multilevel dynamic stabilization:effects on adjacent segment[J].Journal of Spinal Disorders and Techniques,2011,(01):60-67.
  • 8Conesa X,Pel isé F,Nú?ez S. Recurrent adjacent segment disease and cauda equina syndrome[J].European Spine Journal,2011,(Suppl 2):S258-S261.
  • 9Lee KI,Moon SH,Kim H. Tissue engineering of the Intervertebral disc with cultured nucleus pulposus cel s using atelocol agen scaffold and growth factors[J].Spine,2012,(06):452-458.
  • 10Damle SR,Rawlins BA,Boachie-Adjei O. Lumbar spine intervertebral disc gene delivery:A pilot study in Lewis rats[J].HSS Journal,2013,(01):36-41.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部